Jewish General Hospital ( Site 0011)

Montreal, Quebec H9H 4M7

0 studies enrolling now · 1 studies all time

What they study most

Neoplasm

Studies at this site

• Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) — Stopped early